Do You Need to Lose Weight to Prevent Diabetes? Maybe Not

Weight loss has long been considered the top recommendation for preventing type 2 diabetes. In fact, research shows that losing just 5–7% of body weight can reduce the risk of developing diabetes by nearly 60%.

But what about the people who lose weight and still have elevated glucose levels? Or, those who make significant lifestyle changes, don’t lose weight, yet show improvements in their glucose status? Are they simply outliers, fortunate or unfortunate depending on how their metabolism responds?

Emerging research suggests that diabetes prevention is more complex than simply losing weight. Read on to learn what scientists are discovering about metabolic health, insulin sensitivity, and diabetes risk beyond the number on the scale.

Exploring the Link Between Weight and Diabetes

Weight gain, whether driven by aging, physical inactivity, poor dietary patterns, or other medical issues, is often viewed as the primary factor contributing to prediabetes. Without intervention, prediabetes can progress to type 2 diabetes.

This weight-centered view is reflected in the Diabetes Prevention Program (DPP), a nationally accredited initiative designed to stop the progression from prediabetes to diabetes. The DPP identifies weight loss through lifestyle intervention as its primary marker of success, and program reimbursement is tied directly to weight outcomes. After the first six months, clinics receive reduced reimbursement if participants do not meet the required 5% weight loss target, even when measures such as fasting glucose or A1C are improving.

From a high-level perspective, weight gain can increase the risk of diabetes by disrupting how the body processes and responds to insulin. The three key mechanisms involved are insulin resistance, beta-cell stress and decline, and fat storage.

Insulin Resistance

As body fat expands, especially around the liver and pancreas, it drives insulin resistance, meaning cells become less responsive to the insulin the body naturally produces.

Beta-Cell Stress and Decline

To compensate, the pancreas increases insulin output. Over time, this constant demand stresses the beta cells, which gradually lose their ability to produce enough insulin and often experience cellular burnout or death, called apoptosis.

Fat Storage

When energy intake exceeds the capacity of primary fat stores, excess fat begins accumulating in the liver, pancreas, and muscle. This overflow storage worsens insulin resistance and impairs insulin secretion. Fat stored in these key organs is referred to as ectopic fat.

Understanding Body Fat Distribution

While an individual’s fat storage pattern is shaped primarily by genetics and hormones, the body generally prefers to store fat subcutaneously first, then viscerally, and lastly ectopically. This is important because emerging research suggests that where fat is stored may be just as impactful as how much fat a person carries. Understanding body fat distribution offers valuable insight into metabolic health beyond total weight.

Subcutaneous Adipose Tissue (SCAT)

Body fat that sits directly under the skin and can be pinched is known as subcutaneous adipose tissue, or “SCAT.” Although many people may not prefer how this fat looks or feels, it is far less metabolically active and has a weaker impact on metabolic health compared with other fat depots.

Visceral Adipose Tissue (VAT)

In contrast, fat stored deeper in the abdomen, beneath the abdominal muscles, is known as visceral adipose tissue, or “VAT”. Visceral fat is far more metabolically active and strongly associated with insulin resistance, chronic inflammation, and cardiometabolic disease.

Ectopic Fat

Ectopic fat is different. It refers to fat stored within organs or tissues where fat is not meant to accumulate, such as the liver, pancreas, heart, and skeletal muscle. It develops when the body’s primary storage depots, SCAT first and VAT second, can no longer expand safely or efficiently. Excess energy then spills into areas not designed for fat storage, which directly disrupts metabolic function.

Remission Without Weight Loss: What the Science Shows

In a recently publish post-hoc analysis of a large diabetes lifestyle program, researchers found that people who carried more of their fat subcutaneously were able to reverse prediabetes without losing weight. These individuals improved their insulin sensitivity and their ability to produce insulin, allowing blood sugars to return to a normal range through lifestyle intervention.

The story looked different for those with higher amounts of visceral fat, which is strongly linked to inflammation, insulin resistance, and metabolic dysfunction. In this group, lifestyle changes alone were often not enough to restore normal glucose levels unless some visceral fat was lost. Their path to remission typically required weight reduction to improve insulin sensitivity sufficiently for glucose levels to normalize.

Long-term follow-up echoed these findings. Gaining subcutaneous fat did not increase diabetes risk, while gaining visceral fat did.

These findings challenge the long-held assumption that weight loss is the only or even the most important pathway to reversing prediabetes. For some, reducing visceral fat through weight loss may be necessary. For others, lifestyle interventions that improve insulin sensitivity and insulin secretion can restore normal glucose levels without any change on the scale.

The Value of Lifestyle Intervention

Whether weight loss is the goal or not, the foundation of diabetes prevention is lifestyle intervention. Regular physical activity, healthy eating patterns, stress management, restorative sleep, avoiding risky behaviors such as smoking, and maintaining strong social support all play essential roles in improving metabolic health.

Ready to Strengthen Diabetes Care in Your Practice?

If you’re looking to expand your services, improve patient outcomes, or streamline care, I can help. I offer flexible support designed to meet the needs of busy clinics and healthcare providers.

- Diabetes Care & Education. In-office or virtual contract services to help your patients build the confidence and self-management skills they need to thrive.
- Remote Patient Monitoring. Reduce the burden of glucose-related triage while adding a new revenue stream. I provide proactive, at-home glucose support to keep your patients safer and better connected.
- Program Accreditation Support. If you’re ready to launch an accredited diabetes education program, I can guide you through the entire process, from application to implementation, so you can expand your impact and access Medicare reimbursement.

Let’s work together to bring high-quality, patient-centered diabetes care into your practice. Book a discovery call.

References

CDC. Preventing type 2 diabetes with the lifestyle change program. National Diabetes Prevention Program. https://www.cdc.gov/diabetes-prevention/lifestyle-change-program/index.html. Published May 21, 2024. Accessed December 8, 2025.
Sandforth A, Arreola EV, Hanson RL, et al. Prevention of type 2 diabetes through prediabetes remission without weight loss. Nat Med. 2025;31(10):3330-3340. doi:10.1038/s41591-025-03944-9.
Tomita T. Apoptosis in pancreatic β-islet cells in Type 2 diabetes. Bosn J Basic Med Sci. 2016;16(3):162-179. doi:10.17305/bjbms.2016.919.
Snel M, Jonker JT, Schoones J, et al. Ectopic fat and insulin resistance: pathophysiology and effect of diet and lifestyle interventions. Int J Endocrinol. 2012;2012:983814. doi:10.1155/2012/983814
Frank AP, de Souza Santos R, Palmer BF, Clegg DJ. Determinants of body fat distribution in humans may provide insight about obesity-related health risks. J Lipid Res. 2019;60(10):1710-1719. doi:10.1194/jlr.R086975
Klein S, Gastaldelli A, Yki-Järvinen H, Scherer PE. Why does obesity cause diabetes? Cell Metabolism. 2022;34(1):11-20. doi:10.1016/j.cmet.2021.12.012